In 2022,cervical cancer accounted for approximately 662,301 new cases worldwide,representing 6.9%of all cancers diagnosed in women.Furthermore,it was the fourth leading cause of cancer-related deaths among women~1.In ...In 2022,cervical cancer accounted for approximately 662,301 new cases worldwide,representing 6.9%of all cancers diagnosed in women.Furthermore,it was the fourth leading cause of cancer-related deaths among women~1.In China,human papillomavirus(HPV)vaccination is not included in the National Immunization Program,thus creating marked urban±rural disparities:only 5.7%of rural children are vaccinated~2.Local publicly funded initiatives have increased vaccination uptake in some cities(e.g.,Shenzhen pilot;Jinan first-dose coverage>90%among eligible girls)~(3,4).展开更多
Rabies is a vaccine-preventable disease with a global goal of zero human deaths by 2030.However,this currently results in an annual loss of millions of disability-adjusted life years,particularly in developing countri...Rabies is a vaccine-preventable disease with a global goal of zero human deaths by 2030.However,this currently results in an annual loss of millions of disability-adjusted life years,particularly in developing countries[1].China experienced a peak in human rabies cases,with over 3,300 reported incidents in 2007.However,the subsequent implementation of robust measures,including enhanced animal management and Post-Exposure Prophylaxis(PEP),has led to a more than 90%reduction in rabies cases from 2007 to 2023[2].The epidemiological trend of human rabies in Beijing,the capital of China,has similarly undergone three stages since 1973.This study aimed to provide a comprehensive description of the observed epidemiological characteristics in Beijing from 1973 to 2023 and to assess the progress made toward elimination targets.展开更多
Summary What is already known about this topic?The World Health Organization(WHO)varicella vaccines position paper states that countries where varicella is an important public health burden could consider introducing ...Summary What is already known about this topic?The World Health Organization(WHO)varicella vaccines position paper states that countries where varicella is an important public health burden could consider introducing varicella vaccine(VarV)in the routine childhood immunization program(1).VarV has been available for many years in China but is not included in most routine immunization programs in China.展开更多
Summary What is already known about this topic?The coronavirus disease 2019(COVID-19)vaccine development has been progressing,but acceptance of the new vaccines by healthcare workers(HCWs)was not well known prior to a...Summary What is already known about this topic?The coronavirus disease 2019(COVID-19)vaccine development has been progressing,but acceptance of the new vaccines by healthcare workers(HCWs)was not well known prior to approval of COVID-19 vaccines in China.What is added by this report?展开更多
Summary What is already known on this topic?Preclinical trials showed the effectiveness of domestic inactivated vaccine candidates for coronavirus disease 2019(COVID-19).However,it is necessary to evaluate the willing...Summary What is already known on this topic?Preclinical trials showed the effectiveness of domestic inactivated vaccine candidates for coronavirus disease 2019(COVID-19).However,it is necessary to evaluate the willingness of the public to receive future domestic vaccines and to understand factors associated with willingness at the early stages of vaccine development.展开更多
To the Editor:Intranasal spray vaccines(ISVs)can produce cellular immunity against severe acute respiratory syndrome virus 2(SARS-CoV-2)variants and have good safety and protective effects.[1]However,the attitudes of ...To the Editor:Intranasal spray vaccines(ISVs)can produce cellular immunity against severe acute respiratory syndrome virus 2(SARS-CoV-2)variants and have good safety and protective effects.[1]However,the attitudes of vaccination service providers toward ISVs have rarely been studied.This study investigated the attitudes of service providers towards vaccination processes that require optimization and improvement.展开更多
基金supported by grants from the China Association for Science and Technology(KXYJS2024012)the Gates Foundation(INV-006373 and INV-023808)+1 种基金Capital’s Funds for Health Improvement and Research(2024-2-30117)Beijing Municipal Health Commission’s Funds for the Highqualified Public Health Professionals Development Project(Discipline Core-03-36)。
文摘In 2022,cervical cancer accounted for approximately 662,301 new cases worldwide,representing 6.9%of all cancers diagnosed in women.Furthermore,it was the fourth leading cause of cancer-related deaths among women~1.In China,human papillomavirus(HPV)vaccination is not included in the National Immunization Program,thus creating marked urban±rural disparities:only 5.7%of rural children are vaccinated~2.Local publicly funded initiatives have increased vaccination uptake in some cities(e.g.,Shenzhen pilot;Jinan first-dose coverage>90%among eligible girls)~(3,4).
文摘Rabies is a vaccine-preventable disease with a global goal of zero human deaths by 2030.However,this currently results in an annual loss of millions of disability-adjusted life years,particularly in developing countries[1].China experienced a peak in human rabies cases,with over 3,300 reported incidents in 2007.However,the subsequent implementation of robust measures,including enhanced animal management and Post-Exposure Prophylaxis(PEP),has led to a more than 90%reduction in rabies cases from 2007 to 2023[2].The epidemiological trend of human rabies in Beijing,the capital of China,has similarly undergone three stages since 1973.This study aimed to provide a comprehensive description of the observed epidemiological characteristics in Beijing from 1973 to 2023 and to assess the progress made toward elimination targets.
基金Supported by Beijing Natural Science Foundation(L202008).
文摘Summary What is already known about this topic?The World Health Organization(WHO)varicella vaccines position paper states that countries where varicella is an important public health burden could consider introducing varicella vaccine(VarV)in the routine childhood immunization program(1).VarV has been available for many years in China but is not included in most routine immunization programs in China.
文摘Summary What is already known about this topic?The coronavirus disease 2019(COVID-19)vaccine development has been progressing,but acceptance of the new vaccines by healthcare workers(HCWs)was not well known prior to approval of COVID-19 vaccines in China.What is added by this report?
文摘Summary What is already known on this topic?Preclinical trials showed the effectiveness of domestic inactivated vaccine candidates for coronavirus disease 2019(COVID-19).However,it is necessary to evaluate the willingness of the public to receive future domestic vaccines and to understand factors associated with willingness at the early stages of vaccine development.
基金Natural Science Foundation of Beijing Municipality-Haidian Original Innovation Joint Fund Project(No.L222028)Beijing Municipal Science&Technology Commission(No.Z221100007922018)
文摘To the Editor:Intranasal spray vaccines(ISVs)can produce cellular immunity against severe acute respiratory syndrome virus 2(SARS-CoV-2)variants and have good safety and protective effects.[1]However,the attitudes of vaccination service providers toward ISVs have rarely been studied.This study investigated the attitudes of service providers towards vaccination processes that require optimization and improvement.
